DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Rubnitz JE, Inaba H, Dahl G et al.
Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial.
Lancet Oncol 2010;
11: 543-552
We do not assume any responsibility for the contents of the web pages of other providers.